Table 2.
Treatment arms | Stage IIIC ovarian cancer
|
Kruskal–Wallis test P-value | Stage IV ovarian cancer
|
Kruskal–Wallis test P-value | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7-month total cost of care (in 2010 US$)a
|
7-month total cost of care (in 2010 US$)a
|
|||||||||||||
n | Median | Mean | Minimum | Maximum | SD | n | Median | Mean | Minimum | Maximum | SD | |||
Treatment arm | 0.2367 | 0.0299 | ||||||||||||
PDSb | 2,162 | 59,805 | 68,811 | 14,566 | 583,672 | 41,383 | 1,560 | 63,067 | 71,695 | 8,086 | 740,258 | 41,880 | ||
NACTb | 369 | 62,565 | 67,867 | 4,463 | 252,528 | 31,313 | 427 | 60,442 | 64,813 | 3,237 | 200,885 | 30,898 |
Notes:
7-month total cost = Medicare payments for inpatient, outpatient, physician claims, durable medical equipment, home health, and hospice claims within 7 months after diagnosis and adjusted for inflation;
n=12 had missing information. Data represent all claims.
Abbreviations: NACT, neoadjuvant chemotherapy; PDS, primary debulking surgery; SD, standard deviation.